Arjuna Capital Haemonetics Corp Transaction History

Arjuna Capital

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$80.59 - $92.61 $132,006 - $151,695	1,638 Added 7.8%	22,642 $1.94 Million
Q3 2023 Nov 09, 2023	BUY	$82.56 - $93.49 $26,914 - $30,477	326 Added 1.58%	21,004 $1.88 Million
Q2 2023 Aug 09, 2023	BUY	$80.84 - $89.45 $28,859 - $31,933	357 Added 1.76%	20,678 $1.76 Million
Q1 2023 May 15, 2023	SELL	$72.75 - $90.6 $469,383 - $584,551	-6,452 Reduced 24.1%	20,321 $1.68 Million
Q4 2022 Feb 06, 2023	BUY	$73.85 - $86.14 $61,295 - $71,496	830 Added 3.2%	26,773 $2.11 Million
Q3 2022 Nov 01, 2022	BUY	$63.3 - $78.66 $1.64 Million - $2.04 Million	25,943 New	25,943 $1.92 Million
Q2 2020 Aug 13, 2020	SELL	$84.96 - $118.91 $422,421 - $591,220	-4,972 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$74.34 - $121.82 $46,982 - $76,990	632 Added 14.56%	4,972 $496,000
Q4 2019 Jan 30, 2020	BUY	$114.37 - $129.46 $48,950 - $55,408	428 Added 10.94%	4,340 $499,000
Q3 2019 Nov 06, 2019	BUY	$117.16 - $138.52 $27,532 - $32,552	235 Added 6.39%	3,912 $493,000
Q2 2019 Aug 21, 2019	BUY	$81.74 - $120.34 $21,415 - $31,529	262 Added 7.67%	3,677 $442,000
Q2 2019 Aug 08, 2019	BUY	$81.74 - $120.34 $33,104 - $48,737	405 Added 13.46%	3,415 $411,000
Q1 2019 May 14, 2019	BUY	$83.25 - $102.12 $40,376 - $49,528	485 Added 19.21%	3,010 $263,000
Q4 2018 Jan 31, 2019	BUY	$90.66 - $116.63 $6,618 - $8,513	73 Added 2.98%	2,525 $253,000
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $3,778 - $4,812	-42 Reduced 1.68%	2,452 $281,000
Q2 2018 Aug 01, 2018	BUY	$71.53 - $95.75 $178,395 - $238,800	2,494 New	2,494 $224,000

333

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.77B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Arjuna Capital, based on Form 13F filings with the SEC.

Stay updated on Arjuna Capital with notifications on news.